Kwaliteitsstandaard atypische parkinsonismen

Pagina 238 26. Goetz, C.G., et al., Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord, 2008. 23 (15): p. 2129-70. 27. Wenning, G.K., et al., Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS). Mov Disord, 2004. 19 (12): p. 1391-402. 28. Golbe, L.I. and P.A. Ohman-Strickland, A clinical rating scale for progressive supranuclear palsy. Brain, 2007. 130 (Pt 6): p. 1552-65. 29. Folstein, M.F., S.E. Folstein, and P.R. McHugh, "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res, 1975. 12 (3): p. 189-98. 30. Chaudhuri KR, M.-M.P., Brown RG, Sethi K, Stocchi F, Odin P, et al. , The metric properties of a novel non- motor symptoms scale for Parkinson's disease: results from an international pilot study. . Mov Disord. , 2007. 22 : p. 1901–1911. 31. Zigmond AS, S.R., The hospital anxiety and depression scale. . Acta Psychiatr Scand., 1983. 67 : p. 361– 370. . 32. Weintraub D, M.E., Papay K, Shea JA, Xie SX, Siderowf A., Questionnaire for impulsive-compulsive disorders in Parkinson's disease-rating scale. . Mov Disord., 2012. 27 : p. 242–247. 33. Johns, M.W., A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep Breath, 1991. 14 : p. 540–545. 34. Williams, D.R. and I. Litvan, Parkinsonian syndromes. Continuum (Minneap Minn), 2013. 19 (5 Movement Disorders): p. 1189-212. 35. Gilman, S., et al., Second consensus statement on the diagnosis of multiple system atrophy. Neurology, 2008. 71 (9): p. 670-6. 36. Hoglinger, G.U., et al., Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria. Mov Disord, 2017. 32 (6): p. 853-864. 37. Armstrong, M.J., et al., Criteria for the diagnosis of corticobasal degeneration. Neurology, 2013. 80 (5): p. 496-503. 38. Zijlmans, J.C., et al., Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis. Mov Disord, 2004. 19 (6): p. 630-40. 39. Armstrong, R.A., Visual Dysfunction in Parkinson's Disease. Int Rev Neurobiol, 2017. 134 : p. 921-946. 40. Bertram, K. and D.R. Williams, Visual hallucinations in the differential diagnosis of parkinsonism. J Neurol Neurosurg Psychiatry, 2012. 83 (4): p. 448-52. 41. Williams, D.R. and A.J. Lees, What features improve the accuracy of the clinical diagnosis of progressive supranuclear palsy-parkinsonism (PSP-P)? Mov Disord, 2010. 25 (3): p. 357-62. 42. Yoon, W.T., Comparison of dystonia between Parkinson's disease and atypical parkinsonism: The clinical usefulness of dystonia distribution and characteristics in the differential diagnosis of parkinsonism. Neurol Neurochir Pol, 2018. 52 (1): p. 48-53. 43. Santangelo, G., et al., Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. J Neurol, 2018. 265 (11): p. 2602-2613. 44. Lange, K.W., et al., Differentiation of parkinsonian syndromes according to differences in executive functions. J Neural Transm (Vienna), 2003. 110 (9): p. 983-95. 45. Monza, D., et al., Cognitive dysfunction and impaired organization of complex motility in degenerative parkinsonian syndromes. Arch Neurol, 1998. 55 (3): p. 372-8. 46. Robbins, T.W., et al., Cognitive deficits in progressive supranuclear palsy, Parkinson's disease, and multiple system atrophy in tests sensitive to frontal lobe dysfunction. J Neurol Neurosurg Psychiatry, 1994. 57 (1): p. 79-88. 47. Kollensperger, M., et al., Red flags for multiple system atrophy. Mov Disord, 2008. 23 (8): p. 1093-9. 48. Zesiewicz, T.A., K.L. Sullivan, and C.L. Gooch, Red flags to spot the parkinsonian variant of multiple system atrophy. Nat Clin Pract Neurol, 2008. 4 (11): p. 596-7. 49. Abdo, W.F., et al., Ten steps to identify atypical parkinsonism. J Neurol Neurosurg Psychiatry, 2006. 77 (12): p. 1367-9.